Targeting CAF-specific metabolic pathways in breast cancer
Naunyn-Schmiedeberg's Archives of Pharmacology · 2025
DOI: 10.1007/s00210-025-04390-7 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Alaa Khalaf Bediwi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Medical Laboratory Techniques Department, College of Health and Medical Technology, University of Al-Maarif, Anbar, Ramadi, Iraq. Hauptthemen laut MEDLINE: Breast Neoplasms, Cancer-Associated Fibroblasts, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 152 Literaturangaben.
Abstract (Originalsprache)
Breast cancer (BC) cells are distinguished by their capacity to reconfigure metabolism to support rapid growth and survive in hypoxic, nutrient-deficient environments. In the breast tumor microenvironment (TME), metabolic changes-including the Warburg effect, modifications in Krebs cycle intermediates, and adjusted oxidative phosphorylation-are closely associated with the dynamic signaling between tumor cells and stromal elements. Cancer-associated fibroblasts (CAFs), a diverse and adaptable group inside the stroma, significantly influence metabolic pathways, including those regulating glucose, amino acid, and lipid metabolism. Recent research underscores that the metabolic interaction between BC cells and CAFs not only promotes tumor growth and invasion but also facilitates treatment resistance. This review is aimed at consolidating the existing data on the metabolic interactions between BC cells and CAFs, highlighting molecular mechanisms and pathways that could represent potential targets for future therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Laboratory Techniques Department, College of Health and Medical Technology, University of Al-Maarif, Anbar, Ramadi, Iraq.
- Department of Medical Laboratory, College of Applied Medical Sciences, Prince Sattam Bin Abdulaziz University, 11942, Al-Kharj, Saudi Arabia. hjaziahmed703@gmail.com.
- College of Pharmacy, The Islamic University, Najaf, Iraq.
- Department of Medical Analysis, Medical Laboratory Technique College, The Islamic University of Al Diwaniyah, Al Diwaniyah, Iraq.
- Department of Medical Analysis, Medical Laboratory Technique College, The Islamic University of Babylon, Babylon, Iraq.
- Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia.
ORCID-Profile: Ahmed Hjazi, Priya Priyadarshini Nayak
Zitieren
APA
Bediwi, A. K., Hjazi, A., Kedhem, M., Alkhathami, A. G., S, R., Nayak, P. P., Pargaien, A., Singh, U., Hammady, F. J., & Salih, S. A. (2025). Targeting CAF-specific metabolic pathways in breast cancer. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04390-7
Vancouver
Bediwi AK, Hjazi A, Kedhem M, Alkhathami AG, S R, Nayak PP, et al. Targeting CAF-specific metabolic pathways in breast cancer. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-025-04390-7
BibTeX
@article{Bediwi2025,
author = {Bediwi, Alaa Khalaf and Hjazi, Ahmed and Kedhem, Mundher and Alkhathami, Ali G and S, RenukaJyothi and Nayak, Priya Priyadarshini and Pargaien, Amrita and Singh, Udaybir and Hammady, Fathi Jihad and Salih, Salah Abdulhadi},
title = {Targeting CAF-specific metabolic pathways in breast cancer},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2025},
doi = {10.1007/s00210-025-04390-7}
}
EUVIMED